期刊文献+

IKKβ-RNAi腺病毒构建及其HEK293T细胞表达 被引量:1

CONSTRUCTION OF HUMAN IKKβ-TARGETING RNAI ADENOVIRUS VECTOR AND ITS SUPPRESSIVE EFFECT ON THE EXPRESSION OF IKKβIN HEK293T CELLS
下载PDF
导出
摘要 目的构建沉默人IκB激酶β(IKKβ)基因表达的RNA干扰(RNAi)腺病毒,了解其对IKKβ基因表达的作用。方法根据GenBank IKKβ基因的mRNA,利用RNAi Designer工具软件设计合成4对IKKβ基因的特异性小干扰RNA(siRNA),合成互补的寡核苷酸链,构建重组腺病毒,鉴定目的基因。构建IKKβ基因过表达质粒,以与RNAi腺病毒质粒共同转染HEK293T细胞作为实验组,不转染任何质粒的细胞作为空白对照组,共转染过表达质粒和阴性对照病毒载体质粒的HEK293T细胞为阴性对照组,蛋白免疫印迹(Western Blot)方法检测各组HEK293T细胞中IKKβ基因表达。结果成功构建IKKβ-RNAi腺病毒质粒及IKKβ过表达质粒,实验组IKKβ基因表达较空白对照组及阴性对照组下降,差异有显著性(t=49.18、44.648,P<0.05)。结论构建的IKKβ-RNAi腺病毒质粒能有效抑制IKKβ基因表达,为进一步探讨肿瘤的生物治疗提供理论基础。 Objective To construct human IKKβ-targeting RNAi adenovirus vector and observe their gene silencing effect on IKKβ. Methods Four pairs of IKKi3 gene-specific small interfering RNA (siRNA) were designed using the RNAi De- signer software according to mRNA of IKKβ gene complementary oligonucleotides were synthesized, recombinant adenovirus con- structed and target gene identified successfully. Co-transfected HEK293T cells with RNAi adenovirus vector and Over-expression IKKβ plasmid served as the experimental group, those without any plasmid transfeeted cells as blank control group and ceils co- transfected expression plasmids and negative viral vectors as a negative control group. The expressions of IKKβ gene in HEK293T cells in each group were detected using Western Blot. Results RNAi adenovirus vector and over-expression IKKβ plasmid were successfully created, the IKKβ gene expression in the experimental group declined versus both blank-and negative-control groups, the differences being significant (t=49.18,44.648 P〈0.05). Conclusion The constructed IKKβ-RNAi adenovirus plasmid can effectively inhibit the expression of IKKβ. This research provides a theoretical basis for a further study of cancer biotherapy.
出处 《青岛大学医学院学报》 CAS 2015年第1期11-15,共5页 Acta Academiae Medicinae Qingdao Universitatis
基金 国家自然科学基金资助项目(81071852)
关键词 腺病毒科 基因沉默 RNA干扰 质粒 adenoviridae gene silencing RNA interference plasmids
  • 相关文献

参考文献16

  • 1SALMINEN A, HUUSKONEN J, OJALA J, et al. Activa- tion of innate immunity system during aging NF-kB signaling is the molecular culprit of inflamm-aging[J]. Ageing Res Rev, 2008,7(2) 83-105.
  • 2MURRAY P J, WYNN T A. Obstacles and opportunities for understanding macrophage polarization [J]. J Leukoe Biol, 2011,89(4) : 557-563.
  • 3RAMASWAMY G, SLACK F J. siRNA: a guide for RNA si- lencing[J]. Chem Biol, 2002,9(10) : 1053-1055.
  • 4MERT H, YORUK I, ERTEKIN A, et al. Vitamin levels inlung tissue of rats with bleomycin induced pulmonary fibrosis [J]. J Nutr Sci Vitaminol (Tokyo), 2009,55(2):186-190.
  • 5BRUMMELKAMP T R, BERNARDS R, AGAMI R. A sys- tem for stable expression of short interfering RNAs in mam- malian cells[J]. Science, 2002,296 (5567) : 550-553.
  • 6SCHOMBER T, KALBERER C P, WODNAR-FILIPOWICZ A, et al. Gene silencing by lentivirus-mediated delivery of siRNA in human CD34+ cells[J]. Blood, 2004,103(12) :4511- 4513.
  • 7UPRICHARD S L, BOYD B, ALTHAGE A, et al. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpinRNAs[J]. Proc Natl Acad Sci USA, 2005,102 (3): 773-778.
  • 8孙锡同,安伟德,曹亮,胡祥.胃癌腹膜微转移与网膜乳斑的关系[J].中华实验外科杂志,2010(7):902-903. 被引量:2
  • 9KRIST L F, KERREMANS M, BROEKHUIS-FLUITSMA D M, et al. Milky spots in the greater omentum are predominant sites of local tumour cell proliferation and accumulation in the peritoneal cavity [J]. Cancer Immunology Immunotherapy, 1998,47(4) : 205-212.
  • 10OOSTERLING S J, VAN DER BIJ G J, BOGELS M, et al. Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease[J]. Cancer Immunol Immunother, 2006,55 (9) : 1043- 1051.

二级参考文献14

  • 1OLD L J.Tumor necrosis factor (TNF-α)[J].Science,1985,230:630-632.
  • 2BARRY F P,MURPHY J M.Mesenchymal stem cells:clinical applications and biological characterization[J].Int J Biochem Cell Biol,2004,36(4):568-584.
  • 3CARSWELL E A,OLD L J,KASSEL R L,et al.An endotoxin-induced serum factor that causes necrosis of tumors[J].Proc Natl Acad Sci USA,1975,72(9):3666-3670.
  • 4EGGERMONT A M,KOOPS H,LIENARD D,et al.Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas:a multicenter trial[J].Clin Oncol,1996,14(10):2627-2630.
  • 5MARION N W,MAO J J.Mesenchymal stem cells and tissue engineering[J].Methods Enzymol,2006,420:339-361.
  • 6KERN S,EICHLER H,STOEVE J,et al.Comparative ana-lysis of mesenchymal stem cells from bone marrow,umbilical cord blood,or adipose tissue[J].Stem Cells,2006,24(5):1294-1301.
  • 7STUDENY M,FRANK C M,JENNIFER L,et al.Mesenchymal stem cells:potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents[J].Nat Can-cer Ins,2004,96(21):1593-1603.
  • 8AKIRA N,FRANK M,TOSHIYAKI A,et al.Human bone marrow:derived mesenchymal stem cells in the treatment of gliomas[J].Cancer Res,2005,65(8):3307-3317.
  • 9王梽,李良庆.胃癌微转移检测与预后的关系[J].医学综述,2008,14(12):1817-1819. 被引量:2
  • 10周晓彬,纪新强,徐莉.医用统计学软件PPMS 1.5的组成和应用特点[J].齐鲁医学杂志,2009,24(1):29-32. 被引量:297

共引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部